ADAndrew Thomas DeWan

Andrew Thomas DeWan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrew Thomas DeWan has a total of 604 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Imputed Rare‐Variant Aggregate Analysis Is a Powerful Approach to Detect Genetic Associations

    by Tianyi Liu, Paul L. Auer, Gao T. Wang, Elnaz Naderi, Andrew T. DeWan, Suzanne M. Leal

    Imputation can cost‐effectively generate genotypes for millions of variants. This study evaluated the power of performing rare‐variant aggregate association tests using imputed genotypes. UK Biobank exome‐sequence data and variants obtained via imputation using the HRC (r1.1) ( N = 32,488 samples) or TOPMed (r3) ( N = 133,597 samples) reference panels were analyzed. Simulations were used to compare the power of performing rare‐variant aggregate association analysis using either sequence or imputed data. The number of genes available for analysis, that is, those with ≥ 2 rare variants, was approximately the same for exome‐sequence and TOPMed imputed data, but HRC imputed data had ~10% fewer genes. For imputed data, using a less stringent R 2 threshold (i.e., > 0.3 vs. > 0.8) led to greater power to detect aggregate associations due to additional rare variants included in the analysis. Exome‐sequence data provided the highest power to detect rare‐variant aggregate associations. TOPMed imputed variants usually had < 20% reduction in power in comparison to exome‐sequence data, whereas HRC imputed variants provided substantially less power. Rare‐variant aggregate association analyses using exome‐sequence data, and imputed variants for PCSK9 and low‐density lipoprotein and APOC3 and triglyceride levels were also performed. For these analyses, even when only ultra‐rare variants (minor allele frequency < 0.001) were analyzed, significant aggregate associations could be detected for all data types. Although there is a decrease in power for rare‐variant aggregate association tests when analyzing imputed variants compared to sequence data due to missing variants and uncertainty in genotypes, analysis of imputed data is a viable approach to detect rare‐variant aggregate associations when sequence data are unavailable.

  • Open Access

    Gene-Temperature Interactions and Risk of Childhood Acute Lymphoblastic Leukemia

    by Tormod Rogne, Rong Wang, Pin Wang, Kai Chen, Shuangge Ma, Joshua L. Warren, Catherine Metayer, Joseph L. Wiemels, Andrew T. DeWan, Xiaomei Ma

    Background: High ambient temperature in early pregnancy has been linked to an increased risk of childhood acute lymphoblastic leukemia (ALL). To better understand biological mechanisms, the current study evaluated potential interaction between temperature and genetic characteristics. Methods: We used data from California birth records (1982-2008) and California Cancer Registry (1988-2011) to identify ALL cases (n=3,353) diagnosed ≤14 years of age and non-cancer controls (n=3,530) matched 1:1 on sex, race, ethnicity, and birth year and month. Weekly ambient temperatures throughout pregnancy were assessed on a 1-km grid around the birth address, while genetic data were available from a genome-wide association study using neonatal blood spots. We evaluated the association between ambient temperature and ALL risk by quartiles of established genetic risk score for ALL. Next, we formally tested gene-temperature interactions in the association with ALL, correcting for multiple testing, for genes previously identified with epigenetic changes due to both temperature and ALL. All analyses were adjusted for potential confounders. Results: The elevated risk of ALL per 5 °C increase of weekly mean ambient temperature, confined to early pregnancy, was more pronounced among children with the lowest genetic susceptibility to ALL, especially among Latino children (first quartile: odds ratio [OR] = 1.50, 95% confidence interval [CI]: 1.14-1.97); fourth quartile: OR=1.03, 95% CI: 0.83-1.28). There were significant interactions (pBNC1 among non-Latino White children, and suggestive interactions (pTBPL2 and NRXN1 in the full population. Conclusions: Our findings suggest that there may be interactions between ambient temperature in early pregnancy and offspring genotype in the risk of childhood ALL. Impact: If replicated, these findings could help elucidate the biological mechanisms linking high ambient temperature in early pregnancy and the risk of childhood ALL.

  • Open Access

    A higher polygenic score for peripheral artery disease is associated with younger age at surgery among patients undergoing revascularization

    by Jiaqi Hu, Dana Alameddine, Shreef Said, He Wang, Mingfu Yu, Michael Murray, Andrew T. DeWan, Cassius I. Ochoa Chaar

    We examined whether polygenic risk for peripheral artery disease (PAD) is associated with severity among patients undergoing lower extremity revascularization at Yale New Haven Hospital. Patients were classified into European (EUR) and non-European (non-EUR) ancestry groups. Associations between the 19-variant polygenic score (PGS) and nine severity indicators were evaluated using linear and Cox regression models stratified by ancestry, followed by meta-analysis. Significant findings (p < 0.05) were assessed for replication in the UK Biobank (UKB). After quality control, 68 EUR and 59 non-EUR patients were included. In EUR patients, higher PGS was associated with increased risk for stroke (HR = 2.43, 95% CI 1.06–5.57). Meta-analysis revealed a significant association between higher PGS and younger age at surgery (β = –2.90, SE = 1.28), which was replicated in the UKB (β = –0.58, SE = 0.15). These results suggest genetic risk contributes to PAD severity.

  • Maternal cesarean section and offspring ASD or ADHD risk: a Nurses' Health Study II analysis

    by Jingyuan Xiao, Hayon Michelle Choi, Gyeyoon Yim, Tormod Rogne, Andrew T DeWan, Jorge E Chavarro, Marc G Weisskopf, Zeyan Liew

    Epidemiological evidence on whether cesarean delivery influences offspring neurodevelopment remains inconsistent. We evaluated the associations between maternal cesarean delivery and childhood autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in the Nurses’ Health Study II cohort. We included 29 352 mothers and their children in the ASD analysis and 27 704 in the ADHD analysis. We used generalized estimating equations to estimate the odds ratio (OR) and 95% confidence interval (CI) for the child outcomes according to the mode of delivery. We evaluated confounding effects from maternal demographic and reproductive factors, chronic health and pregnancy complications, previous cesarean delivery, and lifestyle factors. We examined current cesarean delivery in combination with the history of mode of delivery, and we performed a sibling comparison analysis to evaluate the influence of uncontrolled confounding. Despite some suggestions in crude analyses, there was no association between birth by cesarean delivery and child ASD (OR = 1.02, 95% CI, 0.81-1.29) nor ADHD (OR = 1.06, 95% CI, 0.95-1.18) in fully adjusted models. Analyses considering maternal history of cesarean deliveries or comparing the siblings did not change the main findings. Our study does not support the hypothesis that birth by cesarean delivery increases the risk of ASD or ADHD.

  • Open Access

    Leveraging cis- and trans- variants to improve protein expression level prediction for proteome-wide association studies

    by Rui Dong, Derek Lamb, Gao T. Wang, Andrew T. DeWan, Suzanne M. Leal

    Since genetic effects are often mediated through proteins, the analysis of proteomic data can provide insights into disease etiology. However, most studies lack proteomic data. To address this problem, we developed TransCisPredict to perform proteome-wide association studies (PWAS) at a biobank scale. TransCisPredict reduces computational burden through linkage-disequilibrium block selection which facilitates incorporating cis- and trans- variants to predict protein expression and performs protein-phenotype association analyses. To account for differences in protein regulatory architecture, four prediction methods are used for weight estimation, i.e., BayesR, Elastic Net, LASSO, and SuSiE. Five-fold cross-validation (CV) is used to select the optimal method for each protein. Weight estimation was performed using White British UK Biobank study subjects (N=42,644) with proteomic and genotype array data. Of the 2,920 available protein expression levels, 2,339 could be predicted with a CV-R 2 >0.05 when cis- and trans- variants were used. Since most methods are limited to cis- variation, for comparison only cis -variants were used for prediction yielding 466 proteins with a CV-R 2 >0.05. A PWAS was performed for 2,339 predicted protein expression levels and type 2 diabetes (T2D) using White British UK Biobank study subjects without proteomic data (N=364,132) followed by two-sample Mendelian randomization using a method that controls for horizontal pleiotropy for validation. Forty proteins were associated with T2D and validated. For the 466 cis- only predicted protein expression levels, three proteins were associated with T2D and validated. Incorporating both cis- and trans- variation using TransCisPredict facilitates the prediction of many more proteins compared to using cis- only variants thereby increasing the power of PWAS.

  • Open Access

    A rapid review of genetic association studies of parent-of-origin effects and fetal growth

    by Esther Joo Won Kang, Andrew Thomas Dewan

    Genetic factors contribute, in part, to fetal growth restriction (FGR), a developmental condition of disrupted fetal development associated with serious health consequences. Among these factors, variants that display parent-of-origin effects (POE) may play a significant role in the variation of human fetal growth. We conducted a synthesis of the available evidence on genetic associations between POE variants and fetal growth traits, aiming to summarize identified variants and compare study designs. Literature searches were performed on the Ovid research platform using the bibliographic databases MEDLINE and Embase, identifying 17 genetic association studies that reported 38 study-wide significant POE variants associated with one or more fetal growth trait(s). Candidate gene approaches were dominant among the studies identified (n = 13), but the application of genome-wide association studies (GWAS) continues to expand as computational phasing and POE determination methods have advanced. While genetic association studies are useful for identifying POE variants, low replication of findings among independent studies remains a major hindrance to validation. Birth weight was the most common measure of fetal growth among our identified studies (n = 15). Further research is needed on alternative measures of fetal growth. Additionally, most of the studies were conducted in sample populations of White European ancestry (n = 9), indicating a gap in research among more diverse populations. Genetic association studies have provided evidence that POE variants contribute to fetal growth variation, encouraging further investigations into the genetic regulation and biological mechanisms underlying fetal growth. The online version contains supplementary material available at 10.1186/s40348-026-00224-5.

  • Open Access

    Association of genetic variants in the autophagy gene ATG4B with asthma

    by Dyema Nicholson, Andrew T. DeWan

    Asthma is a chronic respiratory illness that causes mild to severe inflammation throughout narrowed airways. During allergic airways inflammation, autophagy prevents extensive lung tissue impairment while inducing a protective anti-pathogen response and macrophages in the lung to maintain homeostasis. Previous studies of autophagy genes and asthma have shown an association with variants in ATG5, but a comprehensive analysis of autophagy related genes and asthma has not been performed. Here we utilize summary statistic data generated from a two-stage genome-wide association study (GWAS) of asthma in the UK Biobank. We examined variants in 21 autophagy related genes and found statistically significant associations for 28 variants in two genes in the discovery dataset and nominally significant replication for 16 of these variants, all annotated to ATG4B. This is the first evidence of an association with variants in ATG4B with asthma which provides a novel potential for future drug development.

  • Open Access

    Shared genetic and neuroimmune architecture links type 1 diabetes with neurocognitive traits

    by Priscilla Saarah, Zehra A. Syeda, Ziang Xu, Yikai Dong, Habei Jiang, Michelle Shanguhyia, Sourav Roy, Biqing Zhu, Le Zhang, Andrew T. Dewan, et al.

    Type 1 diabetes, particularly with childhood onset, is associated with altered neurocognitive traits, yet the underlying biological mechanisms are unclear. Here, we integrate genome-wide association results with single-cell epigenomic profiles and show that type 1 diabetes heritability is enriched in accessible chromatin of human brain-resident cells, most notably microglia, across neurodevelopment into adulthood. Bonferroni-corrected cross-trait genetic correlation analyses reveal negative correlations of type 1 diabetes with intelligence, executive function, and bipolar disorder, and a positive correlation with myasthenia gravis. Conjunctional false discovery rate analysis identifies pleiotropic loci jointly influencing type 1 diabetes and neurocognitive traits, including the 17q21.31 neurogenomic hub. Mendelian randomization further demonstrates protective effects of educational attainment, intelligence, Alzheimer’s disease, and bipolar disorder on type 1 diabetes risk, whereas liability to multiple sclerosis and myasthenia gravis increases type 1 diabetes risk. In the reverse direction, liability to type 1 diabetes is associated with increased risk of myasthenia gravis. We identify several gene expression regulatory variants in brain and immune cells that jointly influence type 1 diabetes and neurocognitive traits, some of which show concordant differential expression in disease-affected versus control tissue. Together, these findings highlight pleiotropic genetic and neuroimmune mechanisms that link type 1 diabetes with cognition and neuropsychiatric disease risk.


  • Leveraging pleiotropy to improve genetic risk prediction across diseases

    by Jiaqi Hu, Geyu Zhou, Hongyu Zhao, Andrew T. DeWan


  • Open Access

    Shared genetic factors between lung function and asthma by age at onset

    by Yining Li, Diana M. Cornejo-Sanchez, Rui Dong, Elnaz Naderi, Gao T. Wang, Suzanne M. Leal, Andrew T. DeWan

    The genetic relationship between asthma and lung function may be dependent on age-at-onset (AAO) of asthma. We investigated whether the shared genetics between asthma AAO and lung function is dependent on AAO. Asthma cases from UK Biobank were subset according to their AAO and genetic correlation was used to obtain genetically homogeneous groups, i.e., ≤20 (LT20), 20-40, and >40 (GT40) years. Association analysis and fine-mapping were performed to identify shared genetics between AAO groups and lung function. Mediation and quantitative trait locus (QTL) analyses were performed to identify mechanisms underlying shared genetic associations. Chr5, chr6, chr12, and chr17 each had one region that displayed a cross-phenotype replicated association with at least one AAO group and lung function. Overlapping credible sets obtained from fine-mapping were observed on chr5 and chr6. Mediation analyses demonstrated that for each region the proportion mediated through asthma on lung function was larger for asthma LT20 compared to 20-40 and GT40 suggesting that their effects on lung function were more strongly driven by this association. Tissue-specific QTL analysis revealed shared etiology on chr5 may be acting through SLC22A5 and C5orf56 which might play an important role in decreased lung function among individuals with earlier-onset asthma.